Literature DB >> 18236703

Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study.

Ning Wu1, Sarah L Minden, David C Hoaglin, Louise Hadden, Debra Frankel.   

Abstract

Current knowledge about the health-related quality of life (HRQoL) experienced by people with multiple sclerosis (MS) is limited. We compared item and component scale scores on the Medical Outcomes Short Form 12 (SF-12) of 2,109 people with MS to U.S. norms and published data on persons with other medical conditions. We also built regression models for SF-12-derived mental (MCS) and physical component scale (PCS) scores. Seventy-five percent of the sample had been diagnosed with MS for over 5 years, and one-half to two-thirds received help with at least one activity of daily living (ADL) or instrumental activity of daily living (IADL), respectively. The mean PCS score was 36.2 (Standard Error: 0.27), significantly lower by 14 points than the U.S. population norm and by 4-12 points than mean scores for individuals with diabetes, congestive heart failure, myocardial infarction, hypertension or depression. The mean MCS score was 49.2 (Standard Error: 0.25), significantly lower than the norm for the U.S. population and the mean scores for the chronic condition groups except congestive heart failure and depression. We identified several demographic, disease, and health services factors that were significantly related to quality of life and highlighted a number of areas for improvement. We concluded that the quality of the lives of people with MS could be enhanced by removing barriers to MS care, general health care, and mental health care; meeting needs for help with activities of daily living and instrumental activities of daily living; supporting employment; and improving access to disease modifying agents and symptomatic treatments.

Entities:  

Mesh:

Year:  2007        PMID: 18236703

Source DB:  PubMed          Journal:  J Health Hum Serv Adm        ISSN: 1079-3739


  15 in total

1.  Physical activity, self-efficacy, and health-related quality of life in persons with multiple sclerosis: analysis of associations between individual-level changes over one year.

Authors:  Robert W Motl; Edward McAuley; Daniel Wynn; Brian Sandroff; Yoojin Suh
Journal:  Qual Life Res       Date:  2012-03-09       Impact factor: 4.147

2.  Change in the Health-Related Quality of Life of Multiple Sclerosis Patients over 5 Years.

Authors:  Wonita Janzen; Karen V L Turpin; Sharon A Warren; Ruth Ann Marrie; Kenneth G Warren
Journal:  Int J MS Care       Date:  2013

3.  Effectiveness of a relationship enrichment program for couples living with multiple sclerosis.

Authors:  Sara Anne Tompkins; Jessica Ann Roeder; Jenifer J Thomas; Kimberly K Koch
Journal:  Int J MS Care       Date:  2013

4.  Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community.

Authors:  Nancy J Holland; Diana M Schneider; Robert Rapp; Rosalind C Kalb
Journal:  Int J MS Care       Date:  2011

5.  Cumulative impact of comorbidity on quality of life in MS.

Authors:  R A Marrie; R Horwitz; G Cutter; T Tyry
Journal:  Acta Neurol Scand       Date:  2011-05-26       Impact factor: 3.209

Review 6.  Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.

Authors:  Cindy J Nowinski; Deborah M Miller; David Cella
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

7.  Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.

Authors:  Nicholas G Larocca
Journal:  Patient       Date:  2011       Impact factor: 3.883

8.  Walking speed and health-related quality of life in multiple sclerosis.

Authors:  Christine G Kohn; William L Baker; Matthew F Sidovar; Craig I Coleman
Journal:  Patient       Date:  2014       Impact factor: 3.883

9.  Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.

Authors:  Lindsay I Berrigan; John D Fisk; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Kirsten M Fiest; Kyla A McKay; Ruth Ann Marrie
Journal:  Neurology       Date:  2016-03-09       Impact factor: 9.910

10.  Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.

Authors:  L Shinto; G Marracci; S Baldauf-Wagner; A Strehlow; V Yadav; L Stuber; D Bourdette
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-01-25       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.